We have shown that the optimal therapeutic effect is observed when using the MSC secretome 5- or 10-fold concentrated (with the BDNF content of 15 ng/mL and 30 ng/mL, respectively) being administered intravenously into the tail vein of rats one hour after the modeling of intracerebral hemorrhage. Here, BDNF is linked to intracerebral hemorrhage.